Background The association of long-term air pollution and lung function has not been studied across adult European multi-national populations before. The aim of this study was to determine the association between long-term urban background air pollution and lung function levels, as well as change in lung function among European adults.
Introduction
Spirometric measures of lung function, namely maximum forced vital capacity (FVC) and maximum forced expiratory volume in 1 s (FEV1) are early indicators of chronic respiratory and systemic inflammation, as well as premature cardio-respiratory mortality. 1 These same outcomes have been associated with ambient air pollution, 2 therefore lung function is an important link in the investigation of chronic effects of ambient air pollution.
Lung function increases throughout childhood, peaks around age 20-25, and thereafter slowly decreases. There is strong evidence for an adverse effect of air pollution on lung function growth from the Southern California Children's Health Study. 3 In adults, several cross-sectional studies observed lower levels of lung function in more polluted communities. 4, 5 The Swiss SAPALDIA study is currently the only notable longitudinal study reporting significant associations between long-term exposure to air pollution and decline in lung function, 6 whereas the earlier longitudinal studies had substantial limitations. [7] [8] [9] [10] The European Community Respiratory Health Survey (ECRHS) is the most comprehensive multi-centre respiratory cohort study in adults in Europe. 11 The standardized air pollution protocol of ECRHS was adopted by 21 participating centres. 12 The aim of this project was to test the hypotheses that long-term urban background air pollution was associated with both lung function level (cross-sectional analysis) and change in lung function (longitudinal analysis), respectively.
Methods
Details on the study protocol 11 and lung function data 13 have been published. In brief, participants aged 20-44 were randomly selected from 20 cities in 10 countries. Respiratory health assessment was conducted in 1991-93 and repeated in 2000-2002, using spirometry and administered questionnaires.
Of the 21 centres, 18 used the same spirometer at both occasions. Spirometers at baseline were Biomedin (Padova, Italy) in 12 centres, SensorMedics hot wire spirometer (Yorba Linda, USA) in five centres, SensorMedics dry seal spirometer in two centres and Jaeger Pneumotach (Würzburg, Germany) in two centres. Equipment changed in Erfurt (replaced Jaeger Pneumotach by same model) and Antwerp City and South (switched from SensorMedics dry spirometer to Jaeger Masterscope). The spirometry protocol was consistent with American Thoracic Society (ATS) guidelines. 14 Measurements not fulfilling the ATS criteria for repeatability, extreme outliers, and subjects missing data for either FEV1 or FVC were excluded from the analysis. FEV1, FVC and FEV1/FVC ratio were used as outcomes.
Detailed methods and results of the air pollution assessment were published previously. 12, 15, 16 Fine particles (PM 2.5 ) were measured at one central monitor in each centre. Annual means derived between June 2000 and December 2001 were used as surrogates for long-term air pollution levels, as done in other studies. 4, 5 Thereafter the elemental composition and light absorbance of the particles were analysed using standard methods. 15 Questionnaire information included respiratory symptoms, asthma status, medication use, smoking status, occupational history, household characteristics, residential history, socio-demographic characteristics, sensitization to grass and cat allergens, 17 and bronchial hyper-responsiveness. 18 A three-level hierarchical model (survey, subject, centre) was used, similar to the approach presented by Gauderman and colleagues. 3 A detailed description of the statistical methods is provided in the online supplement.
In brief, the two lung function measurements were regressed against age (centred at mean ¼ 38.4 years). Adjustments were made for time dependent covariates (survey level), time-independent subject-specific covariates (subject level), and centre-specific covariates (centre level). The three levels were integrated into one model using xtmixed in STATA version 9.0 (Statacorp LP, College Station, TX, USA), allowing to assess separate effects of PM 2.5 on lung function level and change in lung function simultaneously.
The main models were adjusted for height and smoking status. To investigate further potential confounding and effect modification, varying degrees of adjustment and various sub-samples were used, respectively. Specific emphasis was put on the sensitivity of the analysis towards adjustment for height and age. All statistical models were stratified by sex.Comparisons of baseline lung function were used to assess potential bias due to loss to follow-up.
Power calculations for significantly detectable effect sizes were conducted in Quanto (version 1.1.1 http:// hydra.usc.edu/gxe) using centre random effects after adjusting for height, age, and smoking status. The size of a significantly (a ¼ 0.05, b ¼ 0.8) detectable effect on FEV1 level (cross-sectional difference) was 39 ml (1.2% of mean FEV1) and 58 ml (1.4%) per PM 2.5 contrast of 10 mg/m 3 , in women and men, respectively, and slightly larger for FVC ($1.5%). These effect sizes are comparable to those reported by others. 4 Relative power was considerably smaller to detect an effect on change in lung function. Significantly detectable effects for change in FEV1 were 4.2 ml/year (16.6% of mean change in FEV1) and 4.8 ml/year (14.5%) per 10 mg/m 3 of PM 2.5 , in women and men, respectively (see online supplement for details).
Results
Lung function was measured in 8864 subjects at baseline and 5610 at follow-up (follow-up rate 63%; range across centres: 43-85%). Limiting the data set to subjects with complete, valid records resulted in a sample of 4290 subjects (ATS criteria not fulfilled: 733 subjects; exclusion of extreme values: 279; incomplete: 308).
Compared with those lost to follow-up, participants were on average 1 year older, slightly more often women (52% vs 49%), less likely to ever have smoked (55% vs 60%), and their lung function was slightly lower (FEV1: 3.78 l vs 3.84 l; FVC: 4.66 l vs 4.57 l) (see online supplement for more details; Table 2 ). The main characteristics of the participants are listed in Table 1 .
Annual mean concentrations of PM 2.5 ranged from 3.7 to 44.7 mg/m 3 across all centres; 16 centres had concentrations between 13 and 24 mg/m 3 ( Figure 1 ) (for a map of the 21 centres, see the online supplement).
Correlations between centre means of subjects' characteristics and PM 2.5 are listed in Table 1 . Centre mean height, mean age at the end of education, and average number of reported respiratory symptoms at follow-up showed the strongest correlations with PM 2.5 (Pearson r ¼ -0.5). (Tables 2 and 3) , nor on change in lung function level over the follow-up period. 19 These null-findings were robust towards adjustment for covariates and within various sub-samples of participants analysed (Table 3; Table 1 in online supplement, and ref. 19 ). As expected, age and height were strong predictors of lung function level (Table 2 ). For example, in women FEV1 was 25.5 ml lower for each additional year of age, whereas it was 31.8 ml higher for each additional centimeter of standing height. The negative effects of current smoking on lung function level were significant in men only, while for change in lung function this was the case in both sexes.
Height was the strongest confounder of the crude negative, though non-significant, association between PM 2.5 and lung function level. Including additional covariates had only minor influence on the PM 2.5 coefficients. As shown in the online supplement, other exposure metrics such as sulfur content on PM 2.5 , light absorbance, or NO 2 were neither associated with lung function and these findings remained similar for seasonal means instead of the annual average (see supplement Table 2 ).
Neither the sub-sample analyses among never smokers, northern, central, or southern centres, centres that all used Biomedin spirometers, subjects who did not move between surveys (long term residents), and movers, (Table 3) nor any additional analyses substantially altered the coefficients for PM 2.5 (see online supplement starting on page 2, including Tables 1 and 8 ). 4 and SALIA. 5 On the other hand, ECRHS was underpowered to detect effects on lung function decline. The observed average decline (25 ml/a and 33 ml/a in FEV1, for women and men, respectively; see Table 1 ) was comparable to other studies. 20 The significantly detectable size of air pollution effects on lung function decline was equivalent to smoking 16 and 23 pack years, in women and men, respectively (ECRHS data). As emphasized in the recent SAPALDIA analyses, there is a need for more powerful studies to investigate effects of air pollution on lung function decline, and availability of individual level long-term exposure data appears to be crucial. 6 Our inability to refute the null hypothesis imposes a challenge in the interpretation of the data. The findings either reflect no adverse effects of urban background air pollution on lung function, or are the result of biases toward the null due to some unresolved methodological issues. It is inherently impossible to 'prove' the null hypothesis, thus, one can only speculate about which of the two possible interpretations is appropriate. Related to the possibility of methodological limitations, factors that may have led to systematic misclassification of centre estimates are the primary concern, since we measured air pollution at the centre level. In the following we address the potential for misclassification of lung function and air pollution, as well as confounding separately.
Lung function assessment Lung function measurements followed a standardized protocol and fulfilled the ATS criteria for reproducibility. Subjects were advised not to smoke or use respiratory medication 1 h before the examination. Individuals who had a respiratory infection in the 3 weeks previous to examination were asked to return at a later point, if possible. Adjustment for short-term effects of air pollution was not feasible, however, because daily air pollution data was not available (84 out of 365 days). 12 Spirometry was conducted by well-trained local personnel, and calibration of spirometers was part of the protocol. Nonetheless, the use of different equipment is a potential source of error in cross community comparisons of lung function. 21 As can be seen in Figures 2 and 3 , type of spirometer was associated with air pollution levels, but centre means of lung function did not depend on the device used.
We conducted several sensitivity analyses based on spirometry related factors. However, limiting our analyses to centres that used Biomedin spirometers, adjustment for short-term respiratory symptoms, or inclusion of measurements not in compliance with Figure 3 Lung function levels across ECHRS centres by type of spirometer used. Wide, bright bars in the background reflect mean lung function levels (percentage of predicted values) across centres using the same type of spirometer. Slim, dark bars in the foreground represent centre means of percentage of predicted lung function. Prediction equations used adjusted for sex, height and age. Note: See Figure 2 ATS criteria did not affect our findings. Moreover, results did not change using simpler, cross-sectional models, such as for example some similar to those used in the cross-sectional analyses of SAPALDIA 4 (see online supplement).
Subjects lost to follow-up might differ from those investigated, which may lead to biased centre mean lung function estimates. As shown in the online supplement, extensive investigations indicate loss to follow-up being an unlikely explanation for the nullfindings.
Characterization of exposure ECRHS conducted the first standardized transEuropean PM 2.5 measurement campaign. 12 Other lung function studies, such as SAPALDIA 4 or the Southern California Children's Health Study 3 successfully used central monitors, similar to the method in ECRHS. The vast majority of studies which linked long term air pollution to health outcomes also used central monitors. 2 This approach assumes that one monitor per city provides an unbiased estimate of the average community exposure to background pollution, in other words a pollution mix of low spatial variability not immediately affected by local sources. PM 2.5 varies relatively little in space, and even less does its sulfur content, 22 which was available from elemental analysis. 15 Using sulfur instead of PM 2.5 did not alter our results, nor did NO 2 , light absorbance or any other available exposure metrics (see online supplement; Pearson correlation PM 2.5 -sulfur: r ¼ 0.87). We measured a range of other constituents of air pollution which are more likely to be influenced by nearby sources, such as NO 2 , 16 reflectance (soot), 15 or oxidative properties of PM 2.5 . 23 Using these exposure markers did not result in any significant associations with lung function (see Table 2 in the online supplement). PM 2.5 may have been overestimated where monitors were located close to roads (<15 m). The exclusion of these centres (Pavia, Turin, Verona, Antwerp City), however, did not affect our results. PM 2.5 measures the mass concentration of a mixture of particles of various sizes and composition, including hundreds of chemical substances. Since the mass of particles only serves as a proxy for unknown causal agents, unmeasured variations in the latter across cities could be a source of bias towards null. As shown earlier, PM 2.5 constituents vary across ECRHS centres, and correlations between constituents across cities vary as well. 15, 23 Another limitation of our study is the lack of past pollution data. In several studies annual means of particulate matter varied little over several years. 4, 5 Historic air pollution data for ECRHS cities were scarce and could not be used in quantitative analyses. 24 Exclusion of Erfurt, where dramatic declines in pollution occurred after the German reunification, did not alter our findings. Findings from SAPALDIA indicate that historic pollution trends may be crucial for pollution effects on lung function decline. In that study, baseline levels of exposure were highly correlated with the change in air quality during followup across eight Swiss communities. 25 All the above mentioned factors may have introduced considerable random error in our exposure estimates and thereby contributed to the observed null-findings.
There are three more fundamental limitations associated with the use of central monitors. First, to observe significant exposure contrasts comparisons across vast geographic areas or between urban and rural communities are required, introducing heterogeneity in the studied populations and increasing potential for confounding. Second, the few pollutants measured at central monitors may not be the most health relevant ones. Third, spatial heterogeneity of the health relevant pollution fraction may be substantial and therefore poorly characterized by central monitors.
Since the planning of ECRHS in the early 1990s, several studies found associations between markers of within-community exposure contrasts and various respiratory health outcomes including mortality. 5, 9, [26] [27] [28] Most of these studies use proximity of subjects' homes to traffic or residential NO 2 measurements. 29, 30 These exposure measures may reflect a different, more toxic type of pollution, in particular fresh tailpipe emissions such as ultra-fine particles. Concentrations of many of these (unmeasured) pollutants can be an order of magnitude higher along busy roads. 31 Living along street canyons or narrow but busy roads is common in European cities underscoring the need for local exposure characterization.
In ECRHS measurements of residential outdoor NO 2 were conducted over one or two 2-week periods for a sub-sample of participants (N ¼ 1634) (Figure 4 ). Due to the lack of repeated measurements long-term estimates based on the measured levels were of limited precision, and no effect of residential NO 2 on lung function could be detected. However, these measurements clearly point out the large within-community contrasts for NO 2 , which are likely to exceed betweencommunity contrasts observed for PM 2.5 . Figure 4 raises considerable doubts about the assumption inherent to the cross-community comparison, namely of ranking community means of subjects' true individual exposures adequately when assessing exposure at the community level. Substantial withincommunity contrasts in true individual exposures are detrimental to this type of analyses.
Confounding ECRHS is well suited to adjust for potential confounders on the individual level, such as physiological characteristics, tobacco smoke and other exposures, socio-economic variables, and various measures of respiratory health. Height was by far the strongest predictor of lung function. Since air pollution was assessed on the centre level, the distribution of PM 2.5 , lung function, and potential confounders across centres is of particular relevance.
Air pollution concentrations and lung function levels roughly follow a north-south gradient across Europe, with the highest pollution levels in northern Italy (Turin, Pavia, Verona) and Spain (Barcelona), and bigger lungs in northern Europe. This crude negative association is confounded by height, as can be seen from Table 3 , because people in northern Europe are taller (Mean difference $ 5 cm). The relatively high negative correlation between height and PM 2.5 across centres (Pearson r ¼ -0.46, Table 1 ) poses a challenge to disentangle a potential, small effect of PM 2.5 from the strong effect of height on lung function levels. We conducted numerous additional analyses using various ways of adjustment for height, none of which yielded a significant association between PM 2.5 and lung function. 19 Identifying and controlling for other factors that might act as confounders or effect modifiers on the centre level is challenging. Centre means of socioeconomic status (proportion of manual profession), level of education (age at the end of education) and exposure to environmental tobacco smoke showed correlations with PM 2.5 of similar magnitude as height, but the effects of their adjustment on PM 2.5 coefficients were small. Similarly, diet may have played a role as an uncontrolled community-level confounder; however, dietary data were not available for this analysis. Furthermore, unknown genetic factors which influence lung function or defense mechanisms could have acted as confounders or effect modifiers.
Stratification by numerous potentially confounding or modifying factors did not alter our findings (see online supplement Table 1 ). Since it is difficult to assess the degree of confounding that remains even after stratification, we conclude that comparisons across more homogeneous populations or within cities or communities would be clearly preferable to reduce the chance of confounding. This may explain the discrepancy between our results and those of SAPALDIA and SALIA. 4, 5 The latter studies compared across far more homogenous populations than is the case for ECRHS.
Modeling approach
In our main models we assessed the effect of air pollution on lung function levels and linear decline in lung function simultaneously. To investigate the sensitivity of our results towards different modeling approaches we conducted multiple additional analyses, including separate cross-sectional models at baseline and follow-up, pooling men and women, log transformation, and non-linear parameters for age and height, among others (see online supplement). None of these models led to significant alterations of the null findings.
Conclusions
Urban background air pollution measured as city specific annual mean PM 2.5 levels was not significantly associated with lung function in this large longitudinal study across 21 European study centres. We believe that these null findings provide important lessons relevant to the interpretation of this and other studies and the planning of future investigations of chronic effects of air pollution. The large geographical range of ECRHS, once seen as a major strength, came along with a significant diversity in exposure and health relevant characteristics across the studied populations.
The community-based exposure characterization led to considerable potential for exposure misclassification without capturing large contrasts of trafficrelated pollution within European cities. Moreover, the heterogeneity of the studied populations and their living environments, and the correlation of air pollution, lung function and various potential confounders along a common north-south gradient within Europe decreased our ability to identify potential effects of air pollution on lung function. We conclude that these inherent limitations need to be resolved in future investigations to more conclusively distinguish between a true null effect and biases toward the null. Figure 1 individual exposure estimates of spatially heterogeneous pollutants, such as traffic exhaust. Future analyses of ECRHS health data could therefore offer the unique opportunity to investigate long-term effects of trafficrelated pollution, as well as the modifying role of local or regional factors across Europe, as done previously for acute air pollution effects. 32 
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